ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $893 | +22.0% | 249,506 | +25.6% | 0.01% | +28.6% |
| Q2 2023 | $732 | -69.6% | 198,634 | -68.0% | 0.01% | -79.4% |
| Q4 2022 | $2,410 | -98.2% | 621,348 | +426.1% | 0.03% | +3300.0% |
| Q3 2021 | $133,000 | +7.3% | 118,099 | +51.5% | 0.00% | 0.0% |
| Q2 2021 | $124,000 | +7.8% | 77,941 | +18.5% | 0.00% | 0.0% |
| Q1 2021 | $115,000 | +248.5% | 65,764 | +473.0% | 0.00% | 0.0% |
| Q2 2020 | $33,000 | – | 11,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |